<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="sub-section" /><meta name="keywords" content="Withdrawal: alcohol; Alcohol: dependence; Benzodiazepines: alcohol withdrawal; Chlordiazepoxide: alcohol withdrawal; Carbamazepine: alcohol withdrawal; Clomethiazole: alcohol withdrawal; Haloperidol: alcohol withdrawal; Olanzapine: alcohol withdrawal; Acamprosate; Naltrexone: alcohol dependence; Disulfiram; Wernicke’s encephalopathy; Alcohol: dependence: thiamine deficiency; Thiamine: alcohol dependence; Pancreatitis: alcohol-related" /><meta name="IX" content="Withdrawal: alcohol; Alcohol: dependence; Benzodiazepines: alcohol withdrawal; Chlordiazepoxide: alcohol withdrawal; Carbamazepine: alcohol withdrawal; Clomethiazole: alcohol withdrawal; Haloperidol: alcohol withdrawal; Olanzapine: alcohol withdrawal; Acamprosate; Naltrexone: alcohol dependence; Disulfiram; Wernicke’s encephalopathy; Alcohol: dependence: thiamine deficiency; Thiamine: alcohol dependence; Pancreatitis: alcohol-related" /><title>4.10.1 Alcohol dependence: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="3683.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="3683.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=3683.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="2055.htm">4 Central nervous system</a> &gt; <a href="3682.htm">4.10 Drugs used in substance dependence</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="3682.htm" title="Previous: 4.10 Drugs used in substance dependence">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="213762.htm" title="Next: Acamprosate">Next page</a> ►</div></div></div></div><div id="p1"><div id="pB"><h1 id="_3683">4.10.1 Alcohol dependence</h1><?highlighter on?><div id="pC" class="jN"><div><p>Excessive drinking
of alcoholic beverages over a prolonged period of time can result
in an alcohol withdrawal syndrome on abrupt cessation of, or marked
reduction in, drinking. The presence and severity of alcohol dependence
can be assessed by <i>The Severity of Alcohol Dependence Questionnaire
(SADQ)</i>; other assessment questionnaires are also available. </p><div class="cAZ"><h2>Acute alcohol withdrawal</h2> <p class="cAX">People with moderate dependence can generally
be treated in a community setting unless they are under 18 years of
age, or are at high-risk of severe reactions or treatment failure.
People with severe dependence should undergo withdrawal in an inpatient
setting; withdrawal in severely dependent patients without medical
support may lead to seizures, delirium tremens, and death. Long-acting
benzodiazepines, usually <a title="BNF:monograph: CHLORDIAZEPOXIDE HYDROCHLORIDE" href="3177.htm#_3177"><b>chlordiazepoxide</b></a>,
are used to attenuate alcohol withdrawal symptoms. In primary care,
fixed-dose reducing regimens are usually used, whilst a symptom-triggered
flexible regimen is used in hospital or other settings where continued
assessment and monitoring is carried out for 24–48 hours, usually
followed by a fixed 5-day reducing dose schedule (sometimes it may
be necessary to continue treatment for up to 10 days). Patients with
decompensated liver disease should be treated under specialist supervision.</p><p><a title="BNF:monograph: CARBAMAZEPINE" href="3577.htm#_3577"><b>Carbamazepine</b></a> [unlicensed
indication] is sometimes used as an alternative
treatment in acute alcohol withdrawal when benzodiazepines are contra-indicated
or not tolerated. <a title="BNF:monograph: CLOMETHIAZOLE" href="3163.htm#_3163"><b>Clomethiazole</b></a> is licensed for use in acute alcohol
withdrawal, but benzodiazepines are preferred. It should only be used
in an inpatient setting and should not be prescribed if the patient
is liable to continue drinking alcohol.</p><p>Patients with marked agitation or hallucinations and those at
risk of delirium tremens (characterised by delirium, hallucinations,
course tremor, and disorientation) may be prescribed antipsychotic
drugs, such as <a title="BNF:monograph: HALOPERIDOL" href="3224.htm#_3224"><b>haloperidol</b></a> or <a title="BNF:monograph: OLANZAPINE" href="56911.htm#_56911"><b>olanzapine</b></a> [unlicensed indication], as adjunctive
therapy to benzodiazepines; antipsychotics should not be used alone
because they do not treat alcohol withdrawal and may lower the seizure
threshold. Delirium tremens is a medical emergency that requires specialist
inpatient care.</p><p>If a patient taking a benzodiazepine as part of a withdrawal
regimen develops alcohol withdrawal seizures, a fast-acting benzodiazepine
(such as intravenous <a title="BNF:monograph: LORAZEPAM" href="3624.htm#_3624"><b>lorazepam</b></a> [unlicensed indication] or rectal <a title="BNF:monograph: DIAZEPAM" href="3618.htm#_3618"><b>diazepam</b></a>) should be prescribed; thereafter an increase
in the dose of oral benzodiazepine should be considered to prevent
further seizures from occurring.</p></div><div class="cAZ"><h2>Alcohol dependence</h2> <p class="cAX"><a title="BNF:monograph-family: Acamprosate" href="213762.htm#_213762"><b>Acamprosate</b></a> and <a title="BNF:monograph: NALTREXONE HYDROCHLORIDE" href="3703.htm#_3703"><b>naltrexone</b></a> [unlicensed indication]
are effective treatments for relapse prevention in patients with alcohol
dependence; <b>disulfiram</b> is an alternative. <a title="BNF:monograph-family: Disulfiram" href="213763.htm#_213763">Disulfiram</a> should only be used in patients
in whom acamprosate and naltrexone are not suitable, or if the patient
prefers disulfiram.</p><p>Patients with
alcohol dependence are at risk of developing Wernicke’s encephalopathy;
patients at high-risk are those who are malnourished, at risk of malnourishment,
or have decompensated liver disease. Parenteral <b>thiamine</b> (as <span class="cZ">Pabrinex</span>®, <a title="BNF:monograph: THIAMINE" href="5103.htm#_5103">section 9.6.2</a>) should be prescribed for treatment of suspected
or confirmed Wernicke’s encephalopathy, and for prophylaxis in alcohol-dependent
patients attending hospital for acute treatment (including treatment
unrelated to alcohol dependence); parenteral prophylaxis may also
be considered for high-risk patients being treated in primary care.
High-dose oral <a title="BNF:monograph: THIAMINE" href="5103.htm#_5103">thiamine</a> should be prescribed following parenteral treatment
until cognitive function is maximised. In primary care, prophylactic
high-dose oral thiamine should be prescribed during acute withdrawal
of alcohol, before planned withdrawal, and for patients not undergoing
withdrawal but who are at high-risk of developing Wernicke’s encephalopathy.</p><p>Patients
with chronic alcohol-related pancreatitis who have symptoms of steatorrhoea
or who have poor nutritional status due to exocrine pancreatic insufficiency
should be prescribed <b>pancreatic enzyme supplements</b> (<a title="BNF:sub-section: Pancreatin" href="2297.htm#_2297">section 1.9.4</a>); supplements are not indicated
when pain is the only symptom.</p><p><b>Corticosteroids</b> (<a title="BNF:sub-section: Glucocorticoid therapy" href="4255.htm#_4255">section 6.3.2</a>) are used in patients with severe
acute alcohol-related hepatitis.</p></div></div></div><?highlighter on?><div id="pS"><p>Sub-sections</p><ul class="jT"><li id="_213762"><a href="213762.htm" title="Acamprosate">Acamprosate</a></li><li id="_213763"><a href="213763.htm" title="Disulfiram">Disulfiram</a></li><li><a href="215629.htm" title="Naltrexone">Naltrexone</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="3682.htm">Previous: 4.10 Drugs used in substance dependence</a> | <a class="top" href="3683.htm#">Top</a> | <a accesskey="]" href="213762.htm">Next: Acamprosate</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>